These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29177849)

  • 1. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Kwak YE; Stein SM; Lim JK
    Dig Dis Sci; 2018 Jan; 63(1):61-71. PubMed ID: 29177849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy.
    Fidan S; Fidan E; Alandağ C; Erkut M; Cosar AM
    Arch Iran Med; 2020 Dec; 23(12):835-841. PubMed ID: 33356341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in hepatitis B virus screening before rituximab therapy: A community-based, safety-net hospital experience.
    Junus K; Aguilar M; Patel P; Irwin D; Yee S; Liu B; Bhuket T; Wong RJ
    Cancer; 2017 Feb; 123(4):650-656. PubMed ID: 27696389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan.
    Yazaki S; Yamauchi T; Higashi T
    Int J Clin Oncol; 2020 Jul; 25(7):1327-1333. PubMed ID: 32200482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low rates of hepatitis B virus screening at the onset of chemotherapy.
    Hwang JP; Fisch MJ; Zhang H; Kallen MA; Routbort MJ; Lal LS; Vierling JM; Suarez-Almazor ME
    J Oncol Pract; 2012 Jul; 8(4):e32-9. PubMed ID: 23180996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
    Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival.
    Chen KL; Chen J; Rao HL; Guo Y; Huang HQ; Zhang L; Shao JY; Lin TY; Jiang WQ; Zou DH; Hu LY; Wirian ML; Cai QQ
    Chin J Cancer; 2015 May; 34(5):225-34. PubMed ID: 26058465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia.
    Chen CY; Huang SY; Cheng A; Chou WC; Yao M; Tang JL; Tsay W; Sheng WH; Tien HF
    PLoS One; 2015; 10(5):e0126037. PubMed ID: 25973905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients receiving immunosuppressive therapy for glomerulonephritis: a retrospective analysis.
    Fang J; Li W; Peng X; Tan Z; Tan M; Zhang C; Wang W; Xu Z; Zhou G
    Int Urol Nephrol; 2017 Mar; 49(3):475-482. PubMed ID: 28032257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.
    Kim E; Yune S; Ha JM; Lee WJ; Hwang JW; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2014 Sep; 61(134):1704-11. PubMed ID: 25436366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence.
    Hall SAL; Shaikh A; Teh K; Tantiongco M; Coghlan D; Karapetis CS; Chinnaratha MA; Woodman R; Muller KR; Wigg AJ
    Intern Med J; 2018 Aug; 48(8):936-943. PubMed ID: 29345413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases.
    Artz AS; Somerfield MR; Feld JJ; Giusti AF; Kramer BS; Sabichi AL; Zon RT; Wong SL
    J Clin Oncol; 2010 Jul; 28(19):3199-202. PubMed ID: 20516452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area.
    Hsu PI; Lai KH; Cheng JS; Kao SS; Li YR; Sun WC; Chen WC; Lin KH; Shin CA; Chiang PH; Li YD; Ou WT; Chen HC; Yu HC
    Hepatology; 2015 Aug; 62(2):387-96. PubMed ID: 26041578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
    Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lie AK; Lai CL; Kwong YL; Yuen MF
    J Clin Oncol; 2014 Nov; 32(33):3736-43. PubMed ID: 25287829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.